BiotechTube

Ketoconazole

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Dermatitis, Seborrheic

Conditions

Dermatitis, Seborrheic

Trial Timeline

Jun 1, 2008 → Apr 1, 2010

NCT ID
NCT00703846

About Ketoconazole

Ketoconazole is a approved stage product being developed by GSK plc for Dermatitis, Seborrheic. The current trial status is completed. This product is registered under clinical trial identifier NCT00703846. Target conditions include Dermatitis, Seborrheic.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00703846ApprovedCompleted

Competing Products

20 competing products in Dermatitis, Seborrheic

See all competitors
ProductCompanyStageHype Score
LebrikizumabEli LillyPhase 3
77
Baricitinib + Placebo + Topical corticosteroidEli LillyPhase 3
77
LebrikizumabEli LillyApproved
85
LebrikizumabEli LillyPhase 3
77
Lebrikizumab + PlaceboEli LillyPhase 3
77
BioLexa- Cohort 1 + BioLexa- Cohort 2 + Placebo + GentamicinHoth TherapeuticsPhase 1
25
LebrikizumabEli LillyPhase 3
77
ASN008Formation BioPhase 2
44
ENS-002Concerto BiosciencesPhase 1
25
nemolizumab (CIM331)Chugai PharmaceuticalPhase 2
52
DS-2741a + PlaceboDaiichi SankyoPhase 1
33
SUN13834 + PlaceboDaiichi SankyoPhase 2
52
5 mg ASB17061 + Placebo + 10 mg ASB17061 + 20 mg ASB17061Daiichi SankyoPhase 2
52
Tacrolimus Ointment 0.03% + Tacrolimus Ointment 0.03%Astellas PharmaPhase 2
52
tacrolimus ointmentAstellas PharmaPhase 3
77
tacrolimus 0.1% + fluticasone 0.005 %Astellas PharmaApproved
85
tacrolimus ointment + pimecrolimus creamAstellas PharmaApproved
85
tacrolimus ointment 0.03% + hydrocortisone acetate ointment 1% + hydrocortisone butyrate ointment 0.1% + Meningitec + AC VAXAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaApproved
85
Tacrolimus Ointment 0.1%Astellas PharmaPhase 2
52

Other Products from GSK plc

Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene + clindamycin phosphate 1.2%/benzoyl peroxide 2.5% and 0.1% tazaroteneApproved
84
Duac® Gel / Differin® GelApproved
84
Acitretin (also called U0279) + Placebo + EtanerceptApproved
84
Epiduo Gel + Duac GelApproved
84
amoxicillinApproved
84